L A Wheeler|L B Sheiner - JoVE Visualize

Showing results (141-150 of 169) with videos related to

Pageof 17

Sort By:

The American Journal of Clinical Nutrition|November 1, 1977

Properties of the Ames Salmonella mutants lodged in the gastrointestinal tract of gnotobiotic ratsP Goldman, L A Wheeler, J H Carter, et al.

Clinical Pharmacokinetics|July 1, 1983

Steady-state pharmacokinetics of phenytoin from routinely collected patient dataT H Grasela, L B Sheiner, B Rambeck, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucomaH Schori, J Kipnis, E Yoles, et al.

The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000

alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemiaJ E Donello, E U Padillo, M L Webster, et al.

Investigative Ophthalmology & Visual Science|November 30, 2000

RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotectionH Levkovitch-Verbin, C Harris-Cerruti, Y Groner, et al.

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 5, 2001

Differential effects of alpha-adrenoceptor agonists on human retinal microvessel diameterC S Spada, A L Nieves, J A Burke, et al.

Agents and Actions|September 1, 1991

AGN 190383, a novel phospholipase inhibitor with topical anti-inflammatory activityG W De Vries, G Lee, L Amdahl, et al.

Antimicrobial Agents and Chemotherapy|December 31, 1998

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 InvestigatorsX J Zhou, L B Sheiner, R T D'Aquila, et al.

Journal of Medicinal Chemistry|May 27, 1994

Synthesis and carbonic anhydrase inhibitory activity of 4-substituted 2-thiophenesulfonamidesJ M Holmes, G C Lee, M Wijono, et al.

Diabetes Care|May 20, 1999

Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experienceC C Van Gils, L A Wheeler, M Mellstrom, et al.

Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:

Pageof 17

The American Journal of Clinical Nutrition|November 1, 1977

Properties of the Ames Salmonella mutants lodged in the gastrointestinal tract of gnotobiotic ratsP Goldman, L A Wheeler, J H Carter, et al.

Clinical Pharmacokinetics|July 1, 1983

Steady-state pharmacokinetics of phenytoin from routinely collected patient dataT H Grasela, L B Sheiner, B Rambeck, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucomaH Schori, J Kipnis, E Yoles, et al.

The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000

alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemiaJ E Donello, E U Padillo, M L Webster, et al.

Investigative Ophthalmology & Visual Science|November 30, 2000

RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotectionH Levkovitch-Verbin, C Harris-Cerruti, Y Groner, et al.

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 5, 2001

Differential effects of alpha-adrenoceptor agonists on human retinal microvessel diameterC S Spada, A L Nieves, J A Burke, et al.

Agents and Actions|September 1, 1991

AGN 190383, a novel phospholipase inhibitor with topical anti-inflammatory activityG W De Vries, G Lee, L Amdahl, et al.

Antimicrobial Agents and Chemotherapy|December 31, 1998

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 InvestigatorsX J Zhou, L B Sheiner, R T D'Aquila, et al.

Journal of Medicinal Chemistry|May 27, 1994

Synthesis and carbonic anhydrase inhibitory activity of 4-substituted 2-thiophenesulfonamidesJ M Holmes, G C Lee, M Wijono, et al.

Diabetes Care|May 20, 1999

Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experienceC C Van Gils, L A Wheeler, M Mellstrom, et al.

Pageof 17